Anxo
Fernández Ferreiro
Publicacións nas que colabora con Anxo Fernández Ferreiro (51)
2024
-
Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models
International Journal of Pharmaceutics, Vol. 652
-
Clinical Effectiveness, Safety, and Compliance of Two Compounded Formulations of Tacrolimus Eye Drops: An Open-Label, Sequential Prospective Study
International Journal of Molecular Sciences, Vol. 25, Núm. 18
-
Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics
International Journal of Pharmaceutics, Vol. 662
-
Quantitative brain [18F]FDG PET beyond normal blood glucose levels
NeuroImage, Vol. 300
-
Role of CYP2D6 and CYP3A4 polymorphisms on aripiprazole and dehydroaripiprazole concentrations in patients undergoing long-acting treatment
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 135
-
Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling
Psychiatry Research, Vol. 333
2023
-
Antifungal Combination Eye Drops for Fungal Keratitis Treatment
Pharmaceutics, Vol. 15, Núm. 1
-
Correction: A Review of Population Pharmacokinetic Analyses of Linezolid (Clinical Pharmacokinetics, (2022), 61, 6, (789-817), 10.1007/s40262-022-01125-2)
Clinical Pharmacokinetics
-
Design and biopharmaceutical preclinical characterisation of a new thermosensitive hydrogel for the removal of gastric polyps
International Journal of Pharmaceutics, Vol. 635, pp. 122706
-
Estudio farmacocinético de adalimumab intravítreo en un modelo de rata con uveítis mediante PET
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
2022
-
A Review of Population Pharmacokinetic Analyses of Linezolid
Clinical Pharmacokinetics, Vol. 61, Núm. 6, pp. 789-817
-
Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence
Pharmaceutics, Vol. 14, Núm. 10
-
PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model
International Journal of Pharmaceutics, Vol. 627
2021
-
Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model
Pharmaceutics, Vol. 13, Núm. 10
-
Base preclínica de sistemas lipídicos nanoestructurados (NLC) cargados con bevacizumab: diseño, desarrollo y caracterización fisicoquímica
RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 87-89
-
Ciclodextrinas oftálmicas: Estudios de irritación y permanencia en la superficie ocular mediante Tomografía por Emisión de Positrones
RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 143-145
-
Development and characterization of a tacrolimus/ hydroxypropyl-β-cyclodextrin eye drop
Pharmaceutics, Vol. 13, Núm. 2, pp. 1-27
-
Development and characterization of inhaled ethanol as a novel pharmacological strategy currently evaluated in a phase ii clinical trial for early-stage sars-cov-2 infection
Pharmaceutics, Vol. 13, Núm. 3
-
Diseño, desarrollo y caracterización de nanopartículas de PLGA cargadas con adalimumab
RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 63-65
-
Evaluación preclínica empleando imagen PET/CT de formulaciones impresas en 3D para el tratamiento de la Enfermedad Inflamatoria Intestinal
RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 275-276